Testing a new drug for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called PRL3-zumab for people with advanced solid tumors (cancers that have spread). The goal is to see if it can shrink tumors or slow their growth. It is an option for patients who have had limited prior treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults aged 18 to 75 with any solid tumor cancer that has spread or is advanced (stage 3-4).
- In good enough health to walk and take care of yourself (ECOG score 0 or 1).
- No more than 3 prior cancer treatments (for stage 1-3 disease).
- Willing to use effective birth control if you could become pregnant or cause pregnancy.
- Adequate liver, kidney, and blood function as shown by blood tests.
- No active hepatitis B, C, or HIV infection, and no untreated or growing brain metastases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called ZE94-0605 for people with advanced solid tumors that haven't responded to standard treatments. The goal is to see if it is safe and can shrink tumors.
This trial tests a new drug called LPM6690176 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and how it affects the body.
This trial tests a new medication for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This Phase 1 trial studies ZG0895.HCl, a new experimental treatment, in people with advanced solid cancers. It’s mainly to check safety and how the body responds, and it may help by shrinking or controlling tumors if the drug works.
This trial tests an experimental drug (TEV‑56278) alone or with another drug (pembrolizumab) for people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if it helps shrink tumors.
This trial tests MPB-1734, a new study drug, in adults with advanced solid tumors that can’t be removed and for which standard treatment has stopped working. It aims to find out how safe it is and whether it can shrink or control the cancer.
Hear when a new Advanced Solid Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.